Form Type: 4

SEC EDGAR Link
Acccession Number:0000902664-19-002373
Date:2019-05-13
Issuer: IMMUNOMEDICS INC (IMMU)
Original Submission Date:

Reporting Person:

AVORO CAPITAL ADVISORS LLC
110 GREENE STREET
SUITE 800 NEW YORK, NY 10012

Reporting Person:

AGHAZADEH BEHZAD
C/O AVORO CAPITAL ADVISORS LLC
110 GREENE STREET, SUITE 800 NEW YORK, NY 10012

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK, $0.01 PAR VALUE PER SHARE ("COMMON STOCK") 2019-05-13 P 500,000 a $15.07 18,214,461 indirect f1,f2
COMMON STOCK 2019-05-14 P 125,000 a $15.40 18,339,461 indirect f1,f2
COMMON STOCK 2019-05-15 P 125,000 a $14.95 18,464,461 indirect f1,f2
COMMON STOCK 0 $0.00 3,849 indirect f3
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the securities reported herein are held on behalf of accounts managed by avoro capital advisors llc (formerly venbio select advisor llc), a delaware limited liability company (the "investment manager") and avoro life sciences fund llc (formerly venbio select fund llc), a delaware limited liability company, a fund managed by the investment manager. behzad aghazadeh ("dr. aghazadeh," and together with the investment manager, the "reporting persons") serves as the portfolio manager and controlling person of the investment manager.
f2 the filing of this statement shall not be deemed an admission that either of the reporting persons is the beneficial owner of the securities reported herein for purposes of section 16 of the securities act of 1934, as amended, or otherwise. each of the reporting persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.
f3 restricted stock units held by dr. aghazadeh.

Elevate your investments